* Eiger Biopharmaceuticals says intends to use net proceeds
of offering to fund clinical development of its portfolio of
four product candidates
Source text for Eikon:
Further company coverage:
The post BRIEF-Eiger biopharmaceuticals announces proposed public offering of common stock appeared first on NASDAQ.